Nucleotide Sequences
QTLs in Region (mRatBN7.2)
RGD ID | Symbol | Name | LOD | P Value | Trait | Sub Trait | Chr | Start | Stop | Species | 70216 | Cm14 | Cardiac mass QTL 14 | 2.1 | heart mass (VT:0007028) | heart wet weight (CMO:0000069) | 3 | 31172320 | 163586636 | Rat | 2301970 | Bw81 | Body weight QTL 81 | 5.19 | body mass (VT:0001259) | body weight (CMO:0000012) | 3 | 41874578 | 155617519 | Rat | 2301971 | Cm71 | Cardiac mass QTL 71 | 4.63 | heart left ventricle mass (VT:0007031) | heart left ventricle weight (CMO:0000776) | 3 | 41874578 | 155617519 | Rat | 1559282 | Emca5 | Estrogen-induced mammary cancer QTL 5 | 3.9 | mammary gland integrity trait (VT:0010552) | percentage of study population developing mammary tumors during a period of time (CMO:0000948) | 3 | 43827364 | 169034231 | Rat | 2292591 | Esta4 | Estrogen-induced thymic atrophy QTL 4 | thymus mass (VT:0004954) | thymus wet weight (CMO:0000855) | 3 | 47233211 | 147415807 | Rat | 1581568 | Rf53 | Renal function QTL 53 | urine total protein amount (VT:0000032) | urine protein excretion rate to body weight ratio (CMO:0001099) | 3 | 56395968 | 161299569 | Rat | 8662816 | Vetf4 | Vascular elastic tissue fragility QTL 4 | 4 | renal artery integrity trait (VT:0010642) | number of ruptures of the internal elastic lamina of the renal arteries (CMO:0002563) | 3 | 59242096 | 157323038 | Rat | 1581546 | Pur13 | Proteinuria QTL 13 | 2.93 | 0.0335 | urine total protein amount (VT:0000032) | urine protein excretion rate (CMO:0000759) | 3 | 78196190 | 146592722 | Rat | 631841 | Niddm39 | Non-insulin dependent diabetes mellitus QTL 39 | 3.36 | blood glucose amount (VT:0000188) | blood glucose level (CMO:0000046) | 3 | 94856903 | 159898684 | Rat | 724532 | Cm17 | Cardiac mass QTL 17 | 2 | heart mass (VT:0007028) | calculated heart weight (CMO:0000073) | 3 | 95735366 | 140735366 | Rat | 1354611 | Despr2 | Despair related QTL 2 | 3.03 | 0.0028 | locomotor behavior trait (VT:0001392) | amount of time spent in voluntary immobility (CMO:0001043) | 3 | 97084464 | 142084464 | Rat | 2293087 | Iddm27 | Insulin dependent diabetes mellitus QTL 27 | 2.68 | blood glucose amount (VT:0000188) | blood glucose level (CMO:0000046) | 3 | 97551417 | 147415807 | Rat | 2312659 | Slep7 | Serum leptin concentration QTL 7 | 0.001 | blood leptin amount (VT:0005667) | serum leptin level (CMO:0000780) | 3 | 98535255 | 168026850 | Rat | 2312670 | Bw94 | Body weight QTL 94 | 0.01 | inguinal fat pad mass (VT:0010424) | inguinal fat pad weight to body weight ratio (CMO:0001253) | 3 | 98535255 | 168026850 | Rat | 2312673 | Scl63 | Serum cholesterol level QTL 63 | 0.001 | blood cholesterol amount (VT:0000180) | serum total cholesterol level (CMO:0000363) | 3 | 98535255 | 168026850 | Rat | 2302373 | Gluco39 | Glucose level QTL 39 | 5.01 | blood glucose amount (VT:0000188) | blood glucose level area under curve (AUC) (CMO:0000350) | 3 | 98535386 | 161695835 | Rat | 619618 | Rf3 | Renal disease susceptibility QTL 3 | 6.5 | 0.001 | urine albumin amount (VT:0002871) | urine albumin excretion rate to body weight ratio (CMO:0001270) | 3 | 107693393 | 152693393 | Rat | 1578754 | Stresp16 | Stress response QTL 16 | 4 | 0.001 | blood renin amount (VT:0003349) | plasma renin activity level (CMO:0000116) | 3 | 112681431 | 157681431 | Rat | 1576306 | Schws3 | Schwannoma susceptibility QTL 3 | 0.001 | nervous system integrity trait (VT:0010566) | percentage of study population developing trigeminal nerve neurilemmomas during a period of time (CMO:0002017) | 3 | 118839124 | 163839124 | Rat | 1598877 | Bp285 | Blood pressure QTL 285 | 1.5 | 0.03 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 3 | 120538241 | 165538241 | Rat | 1300173 | Rf11 | Renal function QTL 11 | 3.38 | renal blood flow trait (VT:2000006) | absolute change in renal blood flow rate (CMO:0001168) | 3 | 121056165 | 145956249 | Rat | 1300159 | Kidm4 | Kidney mass QTL 4 | 3.83 | kidney mass (VT:0002707) | right kidney wet weight to body weight ratio (CMO:0001953) | 3 | 121056165 | 157309487 | Rat | 10755461 | Coatc16 | Coat color QTL 16 | coat/hair pigmentation trait (VT:0010463) | pigmented ventral coat/hair area to total ventral coat/hair area ratio (CMO:0001812) | 3 | 122438700 | 167438700 | Rat | 631541 | Bp81 | Blood pressure QTL 81 | 4 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 3 | 124122556 | 169034231 | Rat | 2303620 | Vencon4 | Ventilatory control QTL 4 | 3.9 | respiration trait (VT:0001943) | tidal volume (CMO:0000222) | 3 | 127162703 | 168026850 | Rat | 631673 | Iddm13 | Insulin dependent diabetes mellitus QTL 13 | 1.3 | 0.663 | blood glucose amount (VT:0000188) | plasma glucose level (CMO:0000042) | 3 | 130193298 | 161695983 | Rat | 1578656 | Vnigr2 | Vascular neointimal growth QTL 2 | 4.2 | artery morphology trait (VT:0002191) | lesioned artery residual lumen area (CMO:0001417) | 3 | 130656562 | 169034231 | Rat | 1578653 | Vnigr3 | Vascular neointimal growth QTL 3 | 3.1 | artery morphology trait (VT:0002191) | artery neointimal hyperplastic lesion area (CMO:0001414) | 3 | 130656562 | 169034231 | Rat | 9589106 | Insul23 | Insulin level QTL 23 | 13.86 | 0.001 | blood insulin amount (VT:0001560) | plasma insulin level (CMO:0000342) | 3 | 131635904 | 169034231 | Rat | 2298477 | Eau4 | Experimental allergic uveoretinitis QTL 4 | 0.0011 | uvea integrity trait (VT:0010551) | experimental autoimmune uveitis score (CMO:0001504) | 3 | 137398739 | 169034231 | Rat | 8552952 | Pigfal13 | Plasma insulin-like growth factor 1 level QTL 13 | blood insulin-like growth factor amount (VT:0010479) | plasma insulin-like growth factor 1 level (CMO:0001299) | 3 | 138799500 | 169034231 | Rat | 1554320 | Bmd1 | Bone mineral density QTL 1 | 12.2 | 0.0001 | femur mineral mass (VT:0010011) | volumetric bone mineral density (CMO:0001553) | 1 | 509108 | 86060548 | Rat | 631688 | Hcas2 | Hepatocarcinoma susceptibility QTL 2 | 3 | 0.0001 | liver integrity trait (VT:0010547) | liver tumorous lesion number (CMO:0001068) | 1 | 5925874 | 115540829 | Rat | 2313062 | Bmd73 | Bone mineral density QTL 73 | 3.9 | 0.0001 | tibia mineral mass (VT:1000283) | compact volumetric bone mineral density (CMO:0001730) | 1 | 11481312 | 82174945 | Rat | 2313065 | Bss67 | Bone structure and strength QTL 67 | 3.1 | 0.0001 | tibia area (VT:1000281) | tibia total energy absorbed before break (CMO:0001736) | 1 | 11481312 | 82174945 | Rat | 2313069 | Bss68 | Bone structure and strength QTL 68 | 2.9 | 0.0001 | tibia size trait (VT:0100001) | tibia total energy absorbed before break (CMO:0001736) | 1 | 11481312 | 82174945 | Rat | 2313075 | Bss66 | Bone structure and strength QTL 66 | 3.4 | 0.0001 | tibia length (VT:0004357) | tibia length (CMO:0000450) | 1 | 11481312 | 82174945 | Rat | 2313077 | Bss69 | Bone structure and strength QTL 69 | 3.5 | 0.0001 | tibia strength trait (VT:1000284) | bone polar moment of inertia (CMO:0001558) | 1 | 11481312 | 82174945 | Rat | 2313092 | Bmd72 | Bone mineral density QTL 72 | 2.5 | 0.0001 | tibia mineral mass (VT:1000283) | total volumetric bone mineral density (CMO:0001728) | 1 | 11481312 | 82174945 | Rat | 2313097 | Bss70 | Bone structure and strength QTL 70 | 3.5 | 0.0001 | tibia strength trait (VT:1000284) | tibia total energy absorbed before break (CMO:0001736) | 1 | 11481312 | 82174945 | Rat | 631495 | Bp96 | Blood pressure QTL 96 | 4.52 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 1 | 22340647 | 102268831 | Rat | 1358359 | Sradr1 | Stress Responsive Adrenal Weight QTL 1 | 4.74 | adrenal gland mass (VT:0010420) | both adrenal glands wet weight (CMO:0000164) | 1 | 30882023 | 123479925 | Rat | 70225 | Bp58 | Blood pressure QTL 58 | 3.3 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 1 | 32356093 | 162846471 | Rat | 1300172 | Bp172 | Blood pressure QTL 172 | 3.56 | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 1 | 32737273 | 90665040 | Rat | 10059597 | Bp377 | Blood pressure QTL 377 | 3.42 | 0.025 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 1 | 32737458 | 199368955 | Rat | 8552900 | Pigfal1 | Plasma insulin-like growth factor 1 level QTL 1 | 7.4 | blood insulin-like growth factor amount (VT:0010479) | plasma insulin-like growth factor 1 level (CMO:0001299) | 1 | 34836858 | 79836858 | Rat | 8552948 | Pigfal11 | Plasma insulin-like growth factor 1 level QTL 11 | 4.7 | blood insulin-like growth factor amount (VT:0010479) | plasma insulin-like growth factor 1 level (CMO:0001299) | 1 | 34836858 | 79836858 | Rat | 9589820 | Insglur3 | Insulin/glucose ratio QTL 3 | 10.75 | 0.001 | blood insulin amount (VT:0001560) | calculated plasma insulin level (CMO:0002170) | 1 | 34836858 | 79836858 | Rat | 2313051 | Bss57 | Bone structure and strength QTL 57 | 3.7 | 0.0001 | tibia strength trait (VT:1000284) | bone polar moment of inertia (CMO:0001558) | 1 | 43284731 | 118944897 | Rat | 2313059 | Bss55 | Bone structure and strength QTL 55 | 3.2 | 0.0001 | tibia size trait (VT:0100001) | tibia midshaft cross-sectional area (CMO:0001717) | 1 | 43284731 | 118944897 | Rat | 2313072 | Bss53 | Bone structure and strength QTL 53 | 4.3 | 0.0001 | tibia length (VT:0004357) | tibia length (CMO:0000450) | 1 | 43284731 | 118944897 | Rat | 2313078 | Bss54 | Bone structure and strength QTL 54 | 3.5 | 0.0001 | tibia area (VT:1000281) | tibia midshaft cross-sectional area (CMO:0001717) | 1 | 43284731 | 118944897 | Rat | 2313094 | Bss58 | Bone structure and strength QTL 58 | 3.7 | 0.0001 | tibia strength trait (VT:1000284) | tibia total energy absorbed before break (CMO:0001736) | 1 | 43284731 | 118944897 | Rat | 2313098 | Bmd70 | Bone mineral density QTL 70 | 3.6 | 0.0001 | tibia mineral mass (VT:1000283) | compact volumetric bone mineral density (CMO:0001730) | 1 | 43284731 | 118944897 | Rat | 2313099 | Bss56 | Bone structure and strength QTL 56 | 2.4 | 0.0001 | tibia size trait (VT:0100001) | tibia midshaft endosteal cross-sectional area (CMO:0001716) | 1 | 43284731 | 118944897 | Rat | 2302059 | Pia36 | Pristane induced arthritis QTL 36 | 3.8 | 0.001 | blood immunoglobulin amount (VT:0002460) | serum immunoglobulin G1 level (CMO:0002115) | 1 | 43333002 | 88333002 | Rat | 2313402 | Anxrr24 | Anxiety related response QTL 24 | aggression-related behavior trait (VT:0015014) | tameness/aggressiveness composite score (CMO:0002136) | 1 | 48963584 | 144267916 | Rat | 4889962 | Bss94 | Bone structure and strength QTL 94 | 3.8 | tibia area (VT:1000281) | tibia-fibula cortical bone endosteal cross-sectional area (CMO:0001722) | 1 | 49361465 | 82174945 | Rat | 1578649 | Bmd8 | Bone mineral density QTL 8 | 4.9 | femur mineral mass (VT:0010011) | trabecular volumetric bone mineral density (CMO:0001729) | 1 | 49393172 | 94393172 | Rat | 1578654 | Bss10 | Bone structure and strength QTL 10 | 4 | femur morphology trait (VT:0000559) | femoral neck cortical cross-sectional area (CMO:0001702) | 1 | 49393172 | 159356837 | Rat | 634314 | Niddm44 | Non-insulin dependent diabetes mellitus QTL 44 | blood glucose amount (VT:0000188) | blood glucose level (CMO:0000046) | 1 | 49393289 | 199050459 | Rat | 6903308 | Scl36 | Serum cholesterol QTL 36 | 2 | 0.0125 | blood cholesterol amount (VT:0000180) | plasma total cholesterol level (CMO:0000585) | 1 | 53863041 | 90532583 | Rat | 4889919 | Bss86 | Bone structure and strength QTL 86 | 4.1 | tibia area (VT:1000281) | tibia midshaft total cross-sectional area (CMO:0001715) | 1 | 53895117 | 82174945 | Rat | 4889929 | Bss87 | Bone structure and strength QTL 87 | 6.7 | tibia area (VT:1000281) | tibia-fibula cortical bone endosteal cross-sectional area (CMO:0001722) | 1 | 53895117 | 82174945 | Rat | 61342 | Bp27 | Blood pressure QTL 27 | 3.4 | 0.0006 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 1 | 56732668 | 98773277 | Rat | 2300164 | Bmd44 | Bone mineral density QTL 44 | 5.4 | 0.0001 | lumbar vertebra mineral mass (VT:0010511) | volumetric bone mineral density (CMO:0001553) | 1 | 56949932 | 101949932 | Rat | 2298545 | Neuinf8 | Neuroinflammation QTL 8 | 4.6 | nervous system integrity trait (VT:0010566) | spinal cord beta-2 microglobulin mRNA level (CMO:0002125) | 1 | 57336763 | 151090257 | Rat | 1300121 | Hrtrt1 | Heart rate QTL 1 | 3.7 | heart pumping trait (VT:2000009) | heart rate (CMO:0000002) | 1 | 65789093 | 115540829 | Rat | 7421628 | Bp361 | Blood pressure QTL 361 | 0.001 | arterial blood pressure trait (VT:2000000) | mean arterial blood pressure (CMO:0000009) | 1 | 66023617 | 118608521 | Rat | 631512 | Scl6 | Serum cholesterol level QTL 6 | 9.6 | blood cholesterol amount (VT:0000180) | serum total cholesterol level (CMO:0000363) | 1 | 72197680 | 90508767 | Rat | 1358192 | Ept13 | Estrogen-induced pituitary tumorigenesis QTL 13 | 3.4 | pituitary gland mass (VT:0010496) | pituitary gland wet weight (CMO:0000853) | 1 | 77494165 | 122494165 | Rat | 10054135 | Gmadr2 | Adrenal mass QTL 2 | 1.97 | 0.0129 | adrenal gland mass (VT:0010420) | both adrenal glands wet weight (CMO:0000164) | 1 | 77857876 | 122857876 | Rat | 1549903 | Bp267 | Blood pressure QTL 267 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 1 | 77876254 | 106047988 | Rat | 61344 | Bp29 | Blood pressure QTL 29 | 7.5 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 1 | 78350581 | 123350581 | Rat | 7411712 | Strs4 | Sensitivity to stroke QTL 4 | 8.7 | cerebrum integrity trait (VT:0010549) | percentage of study population developing cerebrovascular lesions during a period of time (CMO:0000932) | 1 | 78430536 | 123430536 | Rat | 61433 | Cia2 | Collagen induced arthritis QTL 2 | 5 | joint integrity trait (VT:0010548) | joint inflammation composite score (CMO:0000919) | 1 | 78430754 | 91209302 | Rat | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Additional Information
External Database Links
| Database | Acc Id | Source(s) |
| NCBI Gene | 25639 | UniSTS |
| 308401 | UniSTS | |
| 680070 | UniSTS | |
| 686656 | UniSTS | |
| UniSTS | 223052 | UniSTS |